GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer

Condition:   Locally Advanced or Metastatic Breast Cancer Interventions:   Drug: GB491+ Fulvestrant;   Drug: Placebo+Fulvestrant Sponsor:   Genor Biopharma Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials